GLYCOMIMETICS INC·4

Nov 14, 4:11 PM ET

Magnani John L. 4

4 · GLYCOMIMETICS INC · Filed Nov 14, 2022

Insider Transaction Report

Form 4
Period: 2022-11-11
Magnani John L.
DirectorVP of Research, CSO
Transactions
  • Purchase

    Common Stock

    2022-11-11$1.17/sh+45,045$52,703366,078 total
Holdings
  • Common Stock

    (indirect: By GlycoTech Corporation)
    4,845
Footnotes (2)
  • [F1]The Reporting Person purchased the securities on the open market at purchase prices ranging from $1.10 to $1.20 per share, with a weighted average purchase price of $1.17 per share. The Reporting Person undertakes to provide, upon request by the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased at each separate price.
  • [F2]These shares are held by GlycoTech Corporation, of which the reporting person is the sole stockholder.

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION